Last deal

$200M

Amount

Venture - Series Unknown

Stage

02.05.2024

Date

1

all rounds

$200M

Total amount

date founded

Financing round

General

About Company
BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.

Also Known As

TheRas

Number of employees

Last funding type

Venture - Series Unknown

IPO status

Private

Description

BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.

Financials

Funding Rounds
1
1

Number of Funding Rounds

$200M

Money Raised

Their latest funding was raised on 02.05.2024. Their latest investor Aisling Capital. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management is a hedge fund sponsor that focuses on investing in innovative biotechnology and life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Biotechnology

Location

Boston, MA, USA

count Of Investments

173

count Of Exists

12
Omega Funds

Omega Funds

Omega Funds is a global life sciences-based investment firm that specializes in direct secondary transactions.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services

Location

Boston, MA, USA

count Of Investments

104

count Of Exists

17
Co-Investors
Investors
11
2

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
No
Venture - Series Unknown
No
Venture - Series Unknown
Aisling Capital

Aisling Capital

Aisling Capital is a venture capital firm based in New York that focuses on investing in the pharmaceutical and biotechnology sectors.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Venture Capital, Financial Services

Location

New York, NY, USA

count Of Investments

103

count Of Exists

27
EcoR1 Capital

EcoR1 Capital

EcoR1 Capital is a biotech-focused investment advisory firm based in San Francisco.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

San Francisco, CA, USA

count Of Investments

92

count Of Exists

7
Enavate Sciences

Enavate Sciences

Enavate Sciences is a biotech investment firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Menlo Park, CA, USA

total rounds

1

total raised

$300M

count Of Investments

8

Activity

Recent News
0